APOE and Alzheimer disease: Baseline characteristics in our study were as expected for a prodromal Alzheimer's disease population, including the CSF biomarker profile; percentage of APOE ε4 carriers; and IWG-1, IWG-2, and NIA-AA criteria (appendix).